05/11/22 7:00 AMOTC : ELTP managementElite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial OfficerElite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, today announced the appointment of Robert Chen, CPA/MPA, as its Chief Financial Officer (CFO),RHEA-AIneutral
04/04/22 7:00 AMOTC : ELTP fda approvalElite Pharmaceuticals and Praxgen Pharmaceuticals Receive FDA Approval for Generic DoxycyclineElite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that together with Elite's co-development partner, Praxgen Pharmaceuticals LLC, formerly SunGenRHEA-AIneutral
02/14/22 6:25 PMOTC : ELTP earningsElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year Ended December 31, 2021 and Provides Conference Call InformationElite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the third quarter ofRHEA-AIneutral
02/09/22 5:15 PMOTC : ELTP conferencesearningsElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2022 Financial Results on February 15, 2022Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTC PINK:ELTP), a specialty pharmaceutical company developing niche generic products,RHEA-AIneutral
11/15/21 4:45 PMOTC : ELTP earningsElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year Ended September 30, 2021 and Provides Conference Call InformationElite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the second quarterRHEA-AIneutral
11/09/21 8:00 PMOTC : ELTP conferencesearningsElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2022 Financial Results on November 16, 2021Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products,RHEA-AIneutral
08/16/21 4:31 PMOTC : ELTP earningsElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2022 Ended June 30, 2021 and Provides Conference Call InformationElite Pharmaceuticals, Inc. ("Elite" or the "Company”) (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the first quarter ofRHEA-AIneutral
08/10/21 4:30 PMOTC : ELTP conferencesearningsElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2022 Financial Results on August 17, 2021Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announcedRHEA-AIneutral
06/14/21 5:10 PMOTC : ELTP earningsElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conference Call InformationElite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended March 31,RHEA-AIneutral
06/08/21 4:00 PMOTC : ELTP conferencesearningsElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 15, 2021Elite Pharmaceuticals, Inc. ('Elite' or the "Company') (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that it will releaseRHEA-AIneutral